People suffering from depression who received MBCT were 31
percent less likely to suffer a relapse over the next 60 weeks.
The findings, published in the journal JAMA Psychiatry, also
indicated there was no evidence of any harmful effects.
“This new evidence for mindfulness-based cognitive therapy … is
very heartening,” said lead researcher Willem Kuyken, an Oxford
University clinical psychologist and director of the Oxford
Mindfulness Centre.
“While MBCT is not a panacea, it does clearly offer those with a
substantial history of depression a new approach to learning
skills to stay well in the long-term.”